LET'S TALK. 303-429-6448

The Regenexx procedure utilizes expanded autologous mesenchymal stem cells for a variety of orthopedic conditions.  Knee pain  secondary to degenerative changes, post-surgical or trauma has been treated with The Regenexx procedure.

How successful is this therapy?

New data has been released and was posted on their website:

For 126 patients reporting and 29 patients that failed to respond (drop out rate of 23%).  Approximately 75% of these patients were knee replacement candidates, 25% were knee surgery candidates to treat a solitary osteochondral lesion (micro fracture, ACI, MACI):

66.7% of patients are reporting more than 50% improvement.    

43.7% of patients are reporting better than 75% improvement.

Avoiding the risks associated with surgery and anaesthesia with no significant recovery time makes the use of cultured stem cell therapy attractive.